This activity is supported by independent educational grants from AbbVie; Pfizer; Salix Pharmaceuticals; and Takeda Pharmaceutical U.S.A., Inc.
Expiration Date: 12/15/2018
Inflammatory bowel disease (IBD) is a chronic, frequently progressive condition that affects approximately 1 to 1.3 million people in the United States. The outcomes of…go to activity»
This activity is supported by an educational grant from Merck & Co., Inc.
Expiration Date: 1/21/2019
Lung cancer is a leading cause of cancer-related deaths worldwide. It is estimated that 222,500 new cases of lung cancer will occur in the United States in 2018…go to activity»
Expiration Date: 12/23/2018
The landscape of genetic testing and treatment for inherited retinal diseases (IRDs) is rapidly evolving. Keeping up-to-date on clinical trials, ordering and…go to activity»
AKH Inc., Advancing Knowledge in Healthcare and SLACK Incorporated
Expiration Date: 12/31/2020
Topics include very late–onset schizophrenia-like psychosis, depression literacy among Korean American parents, and impulsivity and sensation-seeking personality…go to activity»
This activity is supported by an educational grant from Bausch + Lomb.
Expiration Date: 12/26/2018
Glaucoma is the leading cause of irreversible blindness worldwide, with an estimated 70 million people affected by the condition. With the aging population, it is…go to activity»
Expiration Date: 12/31/2018
This activity presents an update on differential diagnosis of noninfectious uveitis of the posterior segment (NIU-PS) and current and emerging treatments for patients…go to activity»